Exhibit 1
JOINT FILING AGREEMENT
The undersigned hereby agree that the Statement on Schedule 13D, dated September 28, 2026, with respect to the common stock of ADARx Pharmaceuticals, Inc. is filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. Each of the undersigned agrees to be responsible for the timely filing of this Statement, and for the completeness and accuracy of the information concerning itself contained therein. This Joint Filing Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the 2nd day of October 2026.
| ORBIMED ADVISORS LLC | ||
| By: | /s/ Carl L. Gordon | |
| Name: Carl L. Gordon | ||
| Title: Member | ||
| ORBIMED CAPITAL GP VII LLC | ||
| By: | ORBIMED ADVISORS LLC, its managing member | |
| By: | /s/ Carl L. Gordon | |
| Name: Carl L. Gordon | ||
| Title: Member of OrbiMed Advisors LLC | ||
| ORBIMED ADVISORS ISRAEL II LIMITED | ||
| By: | /s/ Carl L. Gordon | |
| Name: Carl L. Gordon | ||
| Title: Director | ||
| ORBIMED ISRAEL GP II, L.P. | ||
| By: | ORBIMED ADVISORS ISREAL II LIMITED, its general partner | |
| By: | /s/ Carl L. Gordon | |
| Name: Carl L. Gordon | ||
| Title: Director of OrbiMed Advisors Israel II Limited | ||
| ORBIMED GENESIS GP LLC | ||
| By: | ORBIMED ADVISORS LLC, its managing member | |
| By: | /s/ Carl L. Gordon | |
| Name: Carl L. Gordon | ||
| Title: Member of OrbiMed Advisors LLC | ||